ANTI DCE (RH 1,2,3) - ARCSA Registration f5341ab5dc9691e69650443e46c0f431
Access comprehensive regulatory information for ANTI DCE (RH 1,2,3) in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID f5341ab5dc9691e69650443e46c0f431 and manufactured by DIAGAST. The device was registered on December 07, 2022.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
Free Database
Powered by Pure Global AI
ARCSA Official Data
IV
f5341ab5dc9691e69650443e46c0f431
ANTI DCE (RH 1,2,3)
ARCSA ID: f5341ab5dc9691e69650443e46c0f431
Device Classification
Risk Class
IV
Product Type
In Vitro Diagnostic
Brand Name
DIAGAST
Commercial Name
19-294 IVD Reagents/Kits, Immunohematology, Blood Pooling
Registration Information
Analysis ID
f5341ab5dc9691e69650443e46c0f431
Registration Date
December 07, 2022
Expiration Date
December 07, 2027
Product Use
ANTI-DCE (RH1,2,3) DETECTS THE PRESENCE OF AT LEAST ONE OF ERYTHROCYTE ANTIGENS: D (RH1), C (RH2) OR E (RH3).
Manufacturer
Product Owner
Name
DIAGAST
Country
FRENCH
Authorized Representative
Address
BARRIO JIPIJAPA STREET: ISLA FERNANDINA NO. N42-40 INTERSECCION ISLA TORTUGA
Phone
2252800